By Dennis Thompson HealthDay ReporterWEDNESDAY, May 20, 2026 (HealthDay News) — Some people with sleep apnea might be able to ...
A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ...
New research shows GLP-1 drugs like Ozempic may reduce sleep apnea severity — here's what the latest science says ...
Positional therapy can be a long-lasting and effective treatment for patients with positional obstructive sleep apnea (OSA), according to research presented at the 2026 ATS International Conference.
Upper Michigan Today welcomes American Academy of Dental Sleep Medicine President Dr. Paul Jacobs to share more of his ...
Researchers recently tested a medicine called AD109 in a large phase 3 clinical trial and found encouraging results. The ...
Today, Sunrise Group, a pioneer in medical device innovation and sleep care, announced that the new generation of its home sleep test, Sunrise Air, has officially received FDA clearance. This ...
New research shows Ozempic may reduce sleep apnea severity by over 50%. Here’s what the science actually says.
Researchers say GLP-1 weight loss medications may significantly reduce sleep apnea severity, especially in younger patients.
May 18 (Reuters) - Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main goal in a late-stage trial, potentially offering a convenient alternative ...
Having both OSA and insomnia makes treatment more complex. Learn why addressing both is critical for heart health and how CBTi can help you stick to CPAP.
Sunrise Group has received clearance from the U.S. Food and Drug Administration (FDA) for its Sunrise Air home sleep test.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results